reports on over 500 constitutional cases including approximately 70 cases involving hearing loss. Next-generation sequencing in the clinical practice allows for a critical review of the literature describing
Coupled with the availability of molecular therapeutic targeting genomically defined population, Next-Generation Sequencing (NGS) based multiplexed genomic profiling has created a growing interest among cancer…
mediated cell lines hold great promise to transform therapeutics in various disease areas. Next-generation sequencing (NGS) is a powerful analytical tool with applications designed throughout the CRISPR-Cas9 workflow
next-generation sequencing (NGS) technologies provides a great volume of genome sequence data even for non-model species. The development of microsatellite markers using these data is a relatively quick
Genomic Medicine (LPGM) at Columbia University Medical Center started to offer clinical whole exome sequencing (WES) in January 2013 and cancer whole exome/transcriptome (CWES) testing a year later ... issued reports on…
addition to 39 advanced exudative AMD patients, 250 healthy individuals for whom exome sequencing data were available were included as a control group. Patients with a history of known environmental ... factors were…
improving the accuracy, speed, and comprehensiveness of testing methods. Among these innovations, Next-Generation Sequencing (NGS) has emerged as a powerful tool that is reshaping the way HIV is diagnosed
intervention. This review provides an overview of the transition from traditional methods to Next-Generation Sequencing (NGS) in the field of viral diagnostics. Traditional diagnostic techniques, such as viral culture
FFPE) samples as daily practice using various methods. Recent studies show that targeted next-generation sequencing (NGS) is a promising diagnostic method with many benefits including simultaneous detection of multiple
easily coupled to detect all possible mutation types in a single sample. Next-generation sequencing (NGS) on whole transcriptome (RNA-Seq) enables comprehensive profiling of expressed mutations. However, low sensitivity
microsatellite markers for C. retropictum by using nextgeneration sequencing. A total of 185,972 sequences containing motifs with a minimum of five repeats motifs were identified from ... expected heterozygosities were…
analysis. When an abnormal newborn screening result indicates a specific disorder, Sanger sequencing of the specific gene of interest can identify the underlying genetic cause of the disorder in many ... sensitivity and…
TP53 in Egyptian CRC patients. The secondary objective was to validate the next-generation sequencing (NGS) technology and to develop a workflow process in the clinical setting. Methodology: This study
TP53 in Egyptian CRC patients. The secondary objective was to validate the next-generation sequencing (NGS) technology and to develop a workflow process in the clinical setting. Methodology: This study
gene expression profiling aids in the prediction of tumor behavior. Despite advances in next-generation sequencing (NGS) to detect mutations, these assays often cannot measure gene expression, leaving
Next-generation sequencing-based somatic mutations detection is becoming a standard analysis in neoplasms, which often requires a matched non-neoplastic sample for excluding germline events. One common tissue source
sequencing and bioinformatics to identify disease geneswhich contribute to risk for MAPS. Methods: Next-generation exome sequencing was performed for 15 MAPS patients and one family with multi-generational arterial